Member Info for roger65

Game of two halves today. Loads of buying this morning but mostly sells since just after lunch.

What does tomorrow hold I wonder...a TR1 would be cool

At least Bob Holt's purchase of shares is now listed above. £350k of his own wonga is a decent start. Intrigued as to where this might lead. Just can't be as bad as the sham from whence it came.....Verditek. Gives me the shivers just thinking about it.

This dude bob Holt as an incredible track record. Really amazing.

The placing price is at 0.1p. Why would it drop a further 90%?

Don't see it jumping 400% though either. If it does then what would you do if you held those 2 BILLION new shares? Quick and easy profit me thinks. Double your money and sell them at .2p. All depends if they're in sticky hands or not.

First thing is first though it would be good to get LSE confirmation about Trading resuming on Thursday. Don't think Lars or the Nomad would have been silly enough to put that date in an RNS unless they already knew that was when it will re-open.

Stockpick - I think cheek is banking on draft Full recommendation being given at the end of this week. IF it lands and they even give out a rough estimate of how many tests might be used by the NHS in the near future (per year) then the sp will fly and a placing hopefully done on the back of such a rise. That's my only hope realistically not to be shafted twice by this stock and my own poor decisions.

And what about a damp squib? lol

Agh 5085 that's mean. I lost out big time on EUA and it still hurts but thanks for the reminder. I wasn't the only one to lose there and EUA is typical of the AIM lies that are foisted on retail investors. What a huge con that turned out to be. Share price went from 4op+ to 1.5p. Ouch

The report suggests the test could be used for approx 35k cases but, as pointed out by Jimi, there isn't the capacity in the lab testing set up to cope with the increased demand. There is also a time factor so I'm thinking the CYP2C19 test may be used in the region of 35k - 50k times. That would still amount to about £3.5 - £4m worth of revenue (not profit). Anything like those figures will change the landscape here. Still worried about the pervasive negative comments from outside sources though within the report. Bit of a knife edge here now - hasn't that been said before of GDR?!

Looks like PEEL want to keep the sp at this level for the time being. Never a level playing field between retail and the pro's

I did Parkez. It says 'It is EXPECTED that Admission will become effective, and dealings in the New Ordinary Shares will commence, at 8:00 a.m. BST on 25 April 2024'

So in fact this isn't confirmed...yet. So now we are expecting another RNS very soon with this confirmed by the LSE.

Where is this news on resuming trading on Thursday? Tks

LSE seems to only have one RNS for CPX today. Hopeless as usual.

Yep hands up AHS. Wrong again. Still not happy with the way the way the BODs have handled everything this last year though. Pleasant surprise to be coming back to market but still no idea how the sp will react to such a massive dilution.

The public Consultation ends on Friday I think and it's possible a draft recommendation will be made but not officially published until July.

If it becomes clear it's not a FULL recommendation - and I take Muminr's points on board that NICE seem to be indicating it will be FULL - then it will be a bad weekend for share holders here. That might in fact precipitate GDR going private or being sold on the cheap. I think for now though Cheek doesn't want to go down that route. He appears to want to be rid of RF and get funding through other means and get the FDA partner announced asap. Someone's already said it, chicken and egg. IMO it's all hanging on this next bit of news from NICE. Hopefully it's good. If it is then sp should fly.

Well, if that 'little gamble' does pay off AHS at cpx I will put my profits here at this price! Can see this steadily climbing all the way to July and then probably the usual 'sell the news' action on results, even if positive.

That they didn’t say a word about the suspension is a clear sign they know this isn’t coming back to market imo. New share holders in and they’ll just now vote to take it private. Usual end result for pis.

I did say yesterday I thought a placing might be coming soon. In terms of the dilution and even the price it’s not too bad but three things bother me now.

Why were existing share holders not given the opportunity to participate in the discounted placing?

An RNS released without any specifics on figures but clearly designed to cause a surge in the sp so the placees could forward sell and, to quote petroinvestor, leave existing share holders ‘holding the baby’ as the sp inevitably drops back to the placing price. Some big sellers yesterday who were clearly in the know. GST might be listed on the main market but the management certainly behave as if they’re running a company on AIM. It’s no wonder funding on LSE is drying up, causing more and more significant under valuations, when investors are so easily hoodwinked and ripped off.

If GST is now generating significant revenue why did they need a larger sum now than in the two previous placings? Why can the company not explain why the figures on GS 20 Exchange are so inaccurate? Why no figures at all?

Going on previous form were wrong receive Further news. Next RNS will be the acquisition and then the July results.

Shabby treatment of existing shares holders. We note move on and wait for some decent results. If on July those are disappointing then I’ll vote with my feet- and money. Only got £11k in here now but obviously less thanks to yesterday and today.

Thanks for a grown up post muminr . I’m glad I’m not the only one that waded through the whole discourse and came to a negative conclusion. I agree that the funding, the FDA partner, it’s all tied on the outcome of this NICE recommendation. Your reasoning for the outcome seems eminently plausible but GDR has seen many false dawns. Is this going to be another? Who knows. Either way Cheek is brave and playing for everything on this news. Time will tell.

Ell if you're in here too Metac.nt you'll be losing too very soon. Seems like I'm not the only one who didn't read the report...

And yet AHS here we are, a whopping 2%+ up. I agree it's ridiculous but something isn't right. There are some clever people out there who would see this as a huge opportunity to make very good money very quickly and yet people aren't piling in.

Tiger, you utter jerk. It’s a public consultation…. Find it on NICE website. You can see every comment made and then the response from the NICE panel. Nothing is hidden and not classified you idiot. Actually read it rather than just saying I’ve read it.

I think Gino was being disingenuous when he said he could see no reason why it wouldn’t granted Full recommendation. When I watched that presentation again the other day the person I was least convinced by was the CFO, who seemed reluctant to say anything and was clearly uncomfortable all the way through it

Yes i pressed the buy button but that was because we were being lied to. The management have not been open or honest about the dreadful state the company was in until it was too late for most investors to do anything about.

Charlatans. Nothing new for a company on AIM.

No, I know, but they are clearly anti